Merck & Co., Inc. (MRK)
148.35
-1.19
(-0.80%)
USD |
NYSE |
Aug 28, 16:00
148.20
-0.15
(-0.10%)
After-Hours: 20:00
Merck Free Cash Flow : 16.06B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.06B |
| March 31, 2026 | 14.12B |
| December 31, 2025 | 12.36B |
| September 30, 2025 | 13.05B |
| June 30, 2025 | 14.72B |
| March 31, 2025 | 17.04B |
| December 31, 2024 | 18.10B |
| September 30, 2024 | 14.84B |
| June 30, 2024 | 13.15B |
| March 31, 2024 | 11.04B |
| December 31, 2023 | 9.143B |
| September 30, 2023 | 13.17B |
| June 30, 2023 | 10.83B |
| March 31, 2023 | 11.26B |
| December 31, 2022 | 14.71B |
| September 30, 2022 | 15.25B |
| June 30, 2022 | 14.40B |
| March 31, 2022 | 12.73B |
| December 31, 2021 | 9.661B |
| September 30, 2021 | 8.413B |
| June 30, 2021 | 5.516B |
| March 31, 2021 | 6.812B |
| December 31, 2020 | 5.824B |
| September 30, 2020 | 6.906B |
| June 30, 2020 | 9.445B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.947B |
| December 31, 2019 | 9.967B |
| September 30, 2019 | 8.973B |
| June 30, 2019 | 7.846B |
| March 31, 2019 | 8.343B |
| December 31, 2018 | 8.307B |
| September 30, 2018 | 8.948B |
| June 30, 2018 | 5.196B |
| March 31, 2018 | 5.321B |
| December 31, 2017 | 4.563B |
| September 30, 2017 | 4.34B |
| June 30, 2017 | 8.514B |
| March 31, 2017 | 6.83B |
| December 31, 2016 | 8.762B |
| September 30, 2016 | 9.435B |
| June 30, 2016 | 9.862B |
| March 31, 2016 | 10.94B |
| December 31, 2015 | 11.14B |
| September 30, 2015 | 5.73B |
| June 30, 2015 | 6.769B |
| March 31, 2015 | 6.468B |
| December 31, 2014 | 6.543B |
| September 30, 2014 | 10.79B |
| June 30, 2014 | 10.36B |
| March 31, 2014 | 10.27B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Pfizer Inc. | 10.99B |
| Bristol Myers Squibb Co. | 11.44B |
| Abbott Laboratories | 7.824B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.37B |
| Cash from Investing (Quarterly) | -5.602B |
| Cash from Financing (Quarterly) | 1.762B |
| Free Cash Flow Per Share (Quarterly) | 1.813 |
| Free Cash Flow to Equity (Quarterly) | -312.00M |
| Free Cash Flow to Firm (Quarterly) | 5.505B |
| Free Cash Flow Yield | 4.36% |